Abstract
Breast tumors display a wide variety of genomic alterations. This review focuses on DNA copy number variations in these tumors as measured by the recently developed microarray-based form of comparative genomic hybridization. The capabilities of this new technology are reviewed. Initial applications of array CGH to the analysis of breast cancer, and the mechanisms by which the particular types of copy number changes might arise are discussed.
Similar content being viewed by others
References
Loeb LA: A mutator phenotype in cancer. Cancer Res 61: 3230-3239, 2001
Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, Waldman F, Pinkel D: Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258: 818-821, 1992
Solinas-Toldo S, Lampel S, Stilgenbauer S, Nickolenko J, Benner A, Dohner H, Cremer T, Lichter P: Matrix-based comparative genomic hybridization: biochips to screen for genomic imbalances. Genes Chromosomes Cancer 20: 399-407, 1997
Pinkel D, Segraves R, Sudar D, Clark S, Poole I, Kowbel D, Collins C, KuoW-L, Chen C, Zhai Y, Dairkee SH, Ljung B-M, Gray JW, Albertson DG: Quantitative high resolution analysis of DNA copy number variation in breast cancer using comparative genomic hybridization to DNA microarrays. Nat Genet 20: 207-211, 1998
Pollack JR, Perou CM, Alizadeh AA, Eisen MB, Pergamenschikov A, Williams CF, Jeffrey SS, Botstein D, Brown PO: Genome-wide analysis of DNA copy-number changes using cDNA microarrays. Nat Genet 23: 41-46, 1999
Snijders AM, Nowak N, Segraves R, Blackwood S, Brown N, Conroy J, Hamilton G, Hindle AK, Huey B, Kimura K, Law S, Myambo K, Palmer J, Ylstra B, Yue JP, Gray JW, Jain AN, Pinkel D, Albertson DG: Assembly of microarrays for genome-wide measurement of DNA copy number by CGH. Nat Genet 29: 263-264, 2001
Klein CA, Schmidt-Kittler O, Schardt JA, Pantel K, Speicher MR, Riethmuller G: Comparative genomic hybridization, loss of heterozygosity, and DNA sequence analysis of single cells. Proc. Natl. Acad. Sci. USA 96: 4494-4499, 1999
Snijders AM, Segraves R, Blackwood S, Pinkel D, Albertson DG: BAC microarray-based comparative genomic hybridization. In: Zhao S, Stodolsky M (eds), Bacterial Artificial Chromosomes: Methods and Protocols, Methods in Molecular Biology, Humana Press, 2002 (in press)
Albertson DG, Ylstra B, Segraves R, Collins C, Dairkee SH, Kowbel D, Kuo W-L, Gray JW, Pinkel D: Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene. Nat Genet 25: 144-146, 2000
Tomlinson GE, Chen TT, Stastny VA, Virmani AK, Spillman MA, Tonk V, Blum JL, Schneider NR, Wistuba II, Shay JW, Minna JD, Gazdar A: Characterization of a breast cancer cell line derived from a germ-line BRCA1 mutation carrier. Cancer Res 58: 3237-3242, 1998
Pauletti G, Godolphin W, Press MF, Slamon DJ: Detection and quantification of HER-2/neu gene amplification in human breast cancer archival material using fluorescence in situ hybridization. Oncogene 13: 63-72, 1996
Hosokawa Y, Arnold A: Mechanism of cyclin D1 (CCND1, PRAD1) overexpression in human cancer cells: analysis of allele-specific expression. Genes Chromosomes Cancer 22: 66-71, 1998
Waldman FM, DeVries S, Chew KL, Moore II DH, Kerlikowske K, Ljung BM: Chromosomal alterations in ductal carcinomas in situ and their in situ recurrences. J Natl Cancer Inst 92: 313-320, 2000
Muleris M, Dutrillaux AM, Olschwang S, Salmon RS, Dutrillaux B: Predominance of normal karyotype in colorectal tumors from hereditary non-polyposis colorectal cancer patients. Genes Chromosomes Cancer 14: 223-226, 1995
Kuo MT, Vyas RC, Jiang L-X, Hittelman WN: Chromosomal breakage at a major fragile site associated with P-glycoprotein gene amplification in multidrug-resistant CHO cells. Mol Cell Biol 14: 5202-5211, 1994
Coquelle A, Pipiras E, Toledo F, Buttin G, Debatisse M: Expression of fragile sites triggers intrachromosomal mammalian gene amplification and sets boundaries to early amplicons. Cell 89: 215-225, 1997
Chernova OB, Chernov MV, Ishizaka Y, Agarwal ML, Stark GR: MYC abrogates p53-mediated cell cycle arrest in N-(phosphonacetyl)-L-aspartate-treated cells, permitting CAD gene amplification. Mol Cell Biol 18: 536-545, 1998
Paulson TG, Almasan A, Brody LL, Wahl GM: Gene amplification in a p53-deficient cell line requires cell cycle progression under conditions that generate DNA breakage. Mol Cell Biol 18: 3089-3100, 1998
Pipiras E, Coquelle A, Bieth A, Debatisse M: Interstitial deletions and intrachromosomal amplification initiated from a double-strand break targeted to a mammalian chromosome. EMBO J 17: 325-333, 1998
Hellman A, Zlotorynski E, Scherer SW, Cheung J, Vincent JB, Smith DI, Trakhtenbrot L, Kerem B: A role for common fragile site induction in amplification of human oncogenes. Cancer Cell 1: 89-97, 2002
Pierce AJ, Stark JM, Araujo FD, Moynahan ME, Berwick M, Jasin M: Double-strand breaks and tumorigenesis. Trends Cell Biol 11: S52-S59, 2001
Forsyth NR, Wright WE, Shay JW: Telomerase and differentiation in multicellular organisms: turn it off, turn it on, and turn it off again. Differentiation 69: 188-197, 2002
Griffith JD, Comeau L, Rosenfield S, Stansel RM, Bianchi A, Moss H, de Lange T: Mammalian telomeres end in a large duplex loop. Cell 97: 503-514, 1999
Riboni R, Casati A, Nardo T, Zaccaro E, Ferretti L, Nuzzo F, Mondello C: Telomeric fusions in cultured human fibroblasts as a source of genomic instability. Cancer Genet Cytogenet 95: 130-136, 1997
McClintock B: Spontaneous alterations in chromosome size and form in Zea mays. Cold Spring Harb Symp Quant Biol 9: 72-81, 1941
Etzell JE, Devries S, Chew K, Florendo C, Molinaro A, Ljung B-M, Waldman FM: Loss of chromosome 16q in lobular carcinoma in situ. Hum Pathol 32: 292-296, 2001
Tsarouha H, Pandis N, Bardi G, Teixeira MR, Andersen JA, Heim S: 1999. Karyotypic evolution in breast carcinomas with i(1)(q10) and der(1;16)(q10;p10) as the primary chromosome abnormality. Cancer Genet Cytogenet 113: 156-161, 1998
Waldman FM, Hwang ES, Etzell J, Eng C, DeVries S, Bennington J, Thor A: Genomic alterations in tubular breast carcinomas. Hum Pathol 32: 222-226, 2001
Pandis N, Heim S, Bardi G, Idvall I, Mandahl N, Mitelman F: Whole-arm t(1;16) and I(1q) as sole anomalies identify gain of 1q as a primary chromosomal abnormality in breast cancer. Genes Chromosomes Cancer 5: 235-238, 1992
Tuck-Muller CM, Narayan A, Tsien F, Smeets DF, Sawyer J, Fiala ES, Sohn OS, Ehrlich M: DNA hypomethylation and unusual chromosome instability in cell lines from ICF syndrome patients. Cytogenet Cell Genet 89: 121-128, 2000
Narayan A, Ji W, Zhang XY, Marrogi A, Graff JR, Baylin SB, Ehrlich M: Hypomethylation of pericentromeric DNA in breast adenocarcinomas. Int J Cancer 77: 833-838, 1998
Brinkley BR: Managing the centrosome numbers game: from chaos to stability in cancer cell division. Trends Cell Biol 11: 18-21, 2001
Lingle WL, Barret SL, Negron VC, D'Assoro AB, Boeneman K, Liu W, Whitehead CM, Reynolds C, Salisbury JL: Centrosome amplification drives chromosomal instability in breast tumor development. Proc Natl Acad Sci USA 99: 1978-1983, 2002
Oki E, Oda S, Maehara Y, Sugimachi K: Mutated genespecific phenotypes of dinucleotide repeat instability in human colorectal carcinoma cell lines deficient in DNA mismatch repair. Oncogene 18: 2143-2147, 1999
Tlsty TD: Normal diploid human and rodent cells lack a detectable frequency of gene amplification. Proc Natl Acad Sci USA 87: 3132-3136
Rizki A, Lundblad V: Defects in mismatch repair promote telomerase-independent proliferation. Nature 411: 713-716, 2001
Henson JD, Neumann AA, Yeager TR, Reddel RR: Alternative lengthening of telomeres in mammalian cells. Oncogene 21: 598-610, 2002
Baselga J:Herceptin alone or in combination with chemotherapy in the treatment of HER2-positive metastatic breast cancer: pivotal trials. Oncology 61Suppl 2: 14-21, 2001
Sokolova IA, Halling KC, Jenkins RB, Burkhardt HM, Meyer RG, Seelig SA, King W: The development of a multitarget, multicolor fluorescence in situ hybridization assay for the detection of urothelial carcinoma in urine. J Mol Diagn 2: 116-123, 2000
Bastian BC, Wesselmann U, Pinkel D, Leboit PE: Molecular cytogenetic analysis of Spitz nevi shows clear differences to melanoma. J Invest Dermatol 113: 1065-1069, 1999
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Albertson, D.G. Profiling Breast Cancer by Array CGH. Breast Cancer Res Treat 78, 289–298 (2003). https://doi.org/10.1023/A:1023025506386
Issue Date:
DOI: https://doi.org/10.1023/A:1023025506386